ProShare Advisors LLC Has $237.76 Million Stock Position in Procter & Gamble Company (The) $PG

ProShare Advisors LLC boosted its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 5.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,547,415 shares of the company’s stock after acquiring an additional 77,098 shares during the quarter. ProShare Advisors LLC owned 0.07% of Procter & Gamble worth $237,760,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of PG. Halbert Hargrove Global Advisors LLC acquired a new stake in Procter & Gamble during the 3rd quarter worth approximately $25,000. Corundum Trust Company INC acquired a new stake in shares of Procter & Gamble during the third quarter worth $32,000. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Procter & Gamble in the second quarter valued at about $34,000. Marquette Asset Management LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at about $37,000. Finally, Manning & Napier Advisors LLC acquired a new position in shares of Procter & Gamble in the third quarter valued at about $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Ma. Fatima Francisco sold 8,000 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $158.00, for a total transaction of $1,264,000.00. Following the sale, the chief executive officer owned 6,571 shares in the company, valued at approximately $1,038,218. The trade was a 54.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 95,903 shares of the company’s stock in a transaction dated Friday, January 23rd. The stock was sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares in the company, valued at approximately $27,601,048.05. This trade represents a 34.43% decrease in their position. The SEC filing for this sale provides additional information. 0.20% of the stock is owned by insiders.

Procter & Gamble Trading Up 0.5%

NYSE PG opened at $159.33 on Monday. The stock’s 50-day simple moving average is $145.75 and its two-hundred day simple moving average is $150.30. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $179.99. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $370.28 billion, a price-to-earnings ratio of 23.60, a PEG ratio of 5.29 and a beta of 0.38.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $22.21 billion during the quarter, compared to analysts’ expectations of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm’s revenue was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.88 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s payout ratio is presently 62.67%.

Analysts Set New Price Targets

PG has been the topic of a number of analyst reports. TD Cowen lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and increased their target price for the stock from $150.00 to $156.00 in a research report on Tuesday, January 27th. Barclays set a $155.00 target price on Procter & Gamble in a report on Friday, January 16th. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Rothschild & Co Redburn upped their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “neutral” rating in a research report on Friday, January 23rd. Finally, BNP Paribas Exane decreased their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a report on Friday, January 16th. Thirteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $167.67.

View Our Latest Analysis on Procter & Gamble

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Market technicals and dividend profile: PG has shown a strong technical bounce (breaking above its 200‑day SMA) and benefits from a steady dividend track record, which is attracting risk‑off flows into staples. 3 Consumer Staples Stocks Breaking Out This Month
  • Positive Sentiment: Brand/innovation catalysts: Analysts note P&G is pushing faster Beauty & Personal Care innovation and premiumization to support pricing power and mix improvement—potentially underpinning revenue and margin resilience. Can Beauty & Personal Care Innovation Drive Procter & Gamble’s Growth?
  • Positive Sentiment: High‑profile marketing push: A Super Bowl / Old Spice immersive experience is a short‑term promotional catalyst that can lift grooming revenues and brand engagement. Old Spice Super Bowl Experience
  • Positive Sentiment: Subsidiary performance and shareholder returns: Procter & Gamble Health (India) reported strong Q3 FY26 results and declared an interim + special payout, underscoring cash generation in some business units. Procter & Gamble Health Posts Strong Q3 FY26 Results
  • Neutral Sentiment: Wall Street positioning: The consensus broker view is a “Moderate Buy” with a ~$167 target—supportive context but not a new catalyst. PG Receives Consensus Recommendation of “Moderate Buy”
  • Neutral Sentiment: Valuation/earnings context: Recent commentary reviews PG’s mixed Q2 results, strong brand campaigns and valuation—useful framing for investors but unlikely to move the stock alone. A Look At Procter & Gamble (PG) Valuation
  • Negative Sentiment: Analyst estimate cuts: Zacks Research trimmed multiple quarterly and FY EPS forecasts (FY2027/FY2028 and selected quarters), which could pressure forward expectations and act as a near‑term headwind. Here is What to Know Beyond Why Procter & Gamble is a Trending Stock
  • Negative Sentiment: Insider selling: CEO Ma. Fatima Francisco sold ~8,000 shares (~$1.26M) and materially reduced her direct holding; while insiders sell for many reasons, some investors view such disclosures negatively. SEC Form 4 – Insider Sale
  • Negative Sentiment: Sector valuation risk: Coverage (e.g., Barron’s) warns consumer staples are “frothy” after the recent run; elevated valuations across defensive names could prompt profit‑taking that weighs on PG. Staples Stocks Are Known for Safety. Now They Look Way Too Frothy.

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.